California State Sen. Scott Wiener, D-San Francisco, recently introduced legislation that would cap cost-sharing for insulin at $35 a month, regardless of whether a patient has public or private ...

Ricks was the only executive who outright agreed to Sanders' demand – at least for Eli Lilly's existing insulin products. "We'll leave our prices as they are for the insulins on the market today," ...

The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance ...

Biosimilar insulin glargine access in Europe correlates with significant price reductions of originator products, enhancing affordability and accessibility. The study observed a 21.6% average price ...

Philadelphia announced a new lawsuit Tuesday against three major drug manufacturers and three pharmacy benefit managers. The city alleges all six are complicit in an insulin pricing scheme to keep the ...

A North Texas hospital system has filed a lawsuit over insulin pricing, joining a growing rank of plaintiffs who are suing manufacturers and others on the grounds of inflating prices of the vital drug ...

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, UnitedHealth Group and several other drug manufacturers accusing the companies of deliberately inflating insulin ...